Eisuke Iwamoto

Nagoya, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

From Effect Sizes to Clinical Probabilities: An Exploratory Methodological Framework for Evidence Interpretation and Communication.

From Effect Sizes to Clinical Probabilities: An Exploratory Methodological Framework for Evidence Interpretation and Communication.

Journal: Cureus

Published: July 21, 2026

RGS1 and CREB5 are direct and common transcriptional targets of ZNF384-fusion proteins.

RGS1 and CREB5 are direct and common transcriptional targets of ZNF384-fusion proteins.

Journal: Cancer medicine

Published: January 18, 2024

EBF1-JAK2 inhibits the PAX5 function through physical interaction with PAX5 and kinase activity.

EBF1-JAK2 inhibits the PAX5 function through physical interaction with PAX5 and kinase activity.

Journal: International journal of hematology

Published: December 25, 2022

Functional inhibition of MEF2 by C/EBP is a possible mechanism of leukemia development by CEBP-IGH fusion gene.

Functional inhibition of MEF2 by C/EBP is a possible mechanism of leukemia development by CEBP-IGH fusion gene.

Journal: Cancer science

Published: June 20, 2022

A high prevalence of myeloid malignancies in progeria with Werner syndrome is associated with p53 insufficiency.

A high prevalence of myeloid malignancies in progeria with Werner syndrome is associated with p53 insufficiency.

Journal: Experimental hematology

Published: January 25, 2022

Unraveling unique features of plasma cell clones in POEMS syndrome with single-cell analysis.

Unraveling unique features of plasma cell clones in POEMS syndrome with single-cell analysis.

Journal: JCI insight

Published: May 17, 2021

Two novel high-risk adult B-cell acute lymphoblastic leukemia subtypes with high expression of CDX2 and IDH1/2 mutations.

Two novel high-risk adult B-cell acute lymphoblastic leukemia subtypes with high expression of CDX2 and IDH1/2 mutations.

Journal: Blood

Published: April 23, 2021

Exosomes secreted from cancer-associated fibroblasts elicit anti-pyrimidine drug resistance through modulation of its transporter in malignant lymphoma.

Exosomes secreted from cancer-associated fibroblasts elicit anti-pyrimidine drug resistance through modulation of its transporter in malignant lymphoma.

Journal: Oncogene

Published: June 28, 2020

Showing 1-8 of 8

Last Updated: 09/26/2026